Sagility Limited (NSE:SAGILITY)
India · Delayed Price · Currency is INR 40.47
-0.57 (-1.39%)
Jun 1, 2026, 3:30 PM IST
Sagility Revenue
In the fiscal year ending March 31, 2026, Sagility had annual revenue of 72.91B INR with 30.90% growth. Sagility had revenue of 20.49B in the quarter ending March 31, 2026, with 30.64% growth.
Revenue
72.91B
Revenue Growth
+30.90%
P/S Ratio
2.60
Revenue / Employee
1.65M
Employees
48,522
Market Cap
189.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 72.91B | 17.21B | 30.90% |
| Mar 31, 2025 | 55.70B | 8.16B | 17.17% |
| Mar 31, 2024 | 47.54B | 5.35B | 12.69% |
| Mar 31, 2023 | 42.18B | 28.33B | 204.55% |
| Mar 31, 2022 | 13.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Piramal Pharma | 88.69B |
| NATCO Pharma | 40.78B |
| Syngene International | 37.39B |
| Eris Lifesciences | 31.15B |
Sagility News
- 20 days ago - Sagility Transcript: Q4 25/26 - Transcripts
- 20 days ago - Sagility Quarterly report: Q4 2026 - Filings
- 20 days ago - Sagility Slides: Q4 2026 - Filings
- 2 months ago - Sagility Transcript: Investor Day 2026 - Transcripts
- 2 months ago - Sagility Slides: FY 2026 - Filings
- 2 months ago - Sagility Slides: Investor presentation - Filings
- 4 months ago - Sagility Transcript: Q3 25/26 - Transcripts
- 4 months ago - Sagility Quarterly report: Q3 2026 - Filings